Sun Pharma Consumer Healthcare announced the introduction of Revital NXT in India, marking the company's first entrance into the nutrition…
Sun Pharmaceutical Industries announced the launch of a special initiative ‘Sunkalp’ for the welfare of doctors, their families and the…
Sun Pharmaceutical Industries announced that one of its wholly owned subsidiaries has entered into a license agreement with Ferring Pharmaceuticals,…
Sun Pharma informed it has acquired the rights to trademarks of diabetes drug Dapagliflozin under brands Oxra, Oxramet and Oxraduo…
The Health Ministry on Friday along with Department of Pharmaceuticals and the Ministry of External Affairs are making proactive efforts…
The National Pharmaceutical Pricing Authority (NPPA) Committee has suggested the retail price of Budesonide IP 9 mg for Sun Pharmaceutical…
Indian subsidiary of Merck Sharp and Dohme (MSD), a drug firm has decided to enter into voluntary licensing agreements for…
As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), the US-based unit of Lupin is…
Sun Pharmaceuticals has received an approval from the Subject Expert Committee (SEC) functional under CDSCO Central Drugs Standard Control Organization,…